Medical News

RSS

New study questions the safety of football turf; warrants further research

According to a study presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), rates for Anterior Cruciate Ligament (ACL) injuries and eversion ankle sprains (where the foot twists outward) are significantly higher in the National Football League (NFL) games played on FieldTurf, an artificial playing surface, as compared to natural grass.

15 Mar 2010

SafeMinds: Government refusal to compensate vaccine-injured children casts doubt on the integrity of national immunization program

Autism and mercury advocacy organization SafeMinds regrets today's ruling by the U.S. Court of Federal Claims against three families who argued that vaccines which contained the mercury-based preservative thimerosal contributed to their child's autism.

15 Mar 2010

CCIH study: Canadians are forced to choose between personal health and financial future

Canadians are increasingly being forced to choose between their personal health and their financial future, according to a study released today by the Canadian Council for Integrated Healthcare.

15 Mar 2010

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Monash Institute of Pharmaceutical Science researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd have developed a new method to deliver medications that may benefit thousands of patients with particular types of cancer, HIV and lymphatic conditions world-wide.

15 Mar 2010

AAPHP urges FDA to reclassify electronic cigarette as tobacco product

The American Association of Public Health Physicians submitted a petition to the US Food and Drug Administration on February 23rd in response to their official stance concerning electronic cigarettes.

15 Mar 2010

Orexigen Therapeutics, Patheon sign long-term agreement for commercial manufacturing of Contrave

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, and Patheon Inc., a global provider of drug development and manufacturing services, announced today a long-term agreement for commercial manufacturing of Contrave® (naltrexone HCL sustained release (SR)/bupropion HCL SR) as well as development of future formulations of Orexigen products.

15 Mar 2010

Nanoparticles provide a targeted version of photothermal therapy for cancer

In a lecture he delivered in 1906, the German physician Paul Ehrlich coined the term Zuberkugel, or "magic bullet," as shorthand for a highly targeted medical treatment.

15 Mar 2010

Painful periods at early age doubles risk of endometriosis

Queensland Institute of Medical Research scientists have identified a new link between strong period pain experienced in adolescence and early adulthood and the risk of endometriosis.

15 Mar 2010

Pelosi: A 'climactic health care vote' as early as next week

Politico: During a Friday meeting with Democratic members, Pelosi told lawmakers to "clear their schedules for next weekend." She also promised "to stay in session until the landmark vote, people present said afterwards."

15 Mar 2010

Insurance fraud booms during recession; Short-term health policies should be selected with caution

"The sour economy is producing a bumper crop of cash-strapped consumers, business owners and shady agents who're fueling a wave of insurance fraud that's keeping regulators and law enforcement officials busy from coast to coast," McClatchy reports.

15 Mar 2010

Combination therapy does not reduce cardiovascular risk in type 2 diabetes patients

Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial.

15 Mar 2010

Medtronic commences clinical evaluation of CoreValve transcatheter aortic valve system

Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc., today announced the start of the first of several new initiatives in a robust international clinical program for its CoreValve transcatheter aortic valve system, a minimally-invasive alternative to open-heart surgery for aortic valve replacement.

15 Mar 2010

Obese type 2 diabetics carry mitochondrial proteins that reduce response to physical exercise

Diet and aerobic exercise are highly effective for the treatment of type 2 diabetes, but not for obese subjects that have developed the disease when very young. A study at the Institute for Research in Biomedicine and Trinity College in Dublin demonstrates that obese subjects between 18 and 25 years of age carry mitochondrial proteins and genes that work abnormally and that these anomalies contribute to generating insulin resistance and a reduced response to physical exercise.

15 Mar 2010

Keystone Symposia receives NIH grant for diversity initiatives

Keystone Symposia on Molecular and Cellular Biology is pleased to announce receipt of a $1.37 million, five-year MARC (Minority Access to Research Careers) Ancillary Training Activities grant from the National Institute of General Medical Sciences of the National Institutes of Health (NIH).

15 Mar 2010

Medafor, Magle Life Sciences of Sweden sign long-term raw material supply agreement

Medafor Inc. announced today that it has signed a long-term raw material supply agreement with Magle Life Sciences of Sweden, the supplier of the key powder component for Medafor’s patented MPH(R) (Microporous Polysaccharide Hemosphere) surgical product, which is used by surgeons to control bleeding in complex surgical operations.

15 Mar 2010

Ligand Pharmaceuticals: GSK granted marketing authorization from EC for Revolade

Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).

15 Mar 2010

Health bill update: Pelosi counting votes, Scott Brown lambastes Dems

News outlets reported that Democrats seeking to pass a health bill next week got a boost from a Cabinet official, a key senator and the Catholic Health Association, while newly-elected Sen. Scott Brown, R-Mass., attacked the Democrats' plans.

15 Mar 2010

Two controlled environmental variables to preclinical mice tests can reduce costly false positives: Study

For decades, the traditional practice in animal testing has been standardization, but a study involving Purdue University has shown that adding as few as two controlled environmental variables to preclinical mice tests can greatly reduce costly false positives, the number of animals needed for testing and the cost of pharmaceutical trials.

15 Mar 2010

New study finds green tea extract may prevent Alzheimer's disease and dementia

Long known to be beneficial in heart disease, diabetes and some cancers, a new study finds a specific green tea extract may delay or prevent Alzheimer's disease and dementia. A. Holliday & Company's "Teawell 50," is a 50 percent pure extraction of EGCG (epigallocatechin gallate) – a flavonoid which is the most potent of four major catechins in green tea.

15 Mar 2010

New hydrosurgery system may help manage excessive bleeding during surgery

Carnegie Mellon University's Matt Oberdier is developing a new hydrosurgery system to help physicians better manage excessive bleeding during surgery.

15 Mar 2010

Medical News

New study questions the safety of football turf; warrants further research

SafeMinds: Government refusal to compensate vaccine-injured children casts doubt on the integrity of national immunization program

CCIH study: Canadians are forced to choose between personal health and financial future

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

AAPHP urges FDA to reclassify electronic cigarette as tobacco product

Orexigen Therapeutics, Patheon sign long-term agreement for commercial manufacturing of Contrave

Nanoparticles provide a targeted version of photothermal therapy for cancer

Painful periods at early age doubles risk of endometriosis

Pelosi: A 'climactic health care vote' as early as next week

Insurance fraud booms during recession; Short-term health policies should be selected with caution

Combination therapy does not reduce cardiovascular risk in type 2 diabetes patients

Medtronic commences clinical evaluation of CoreValve transcatheter aortic valve system

Obese type 2 diabetics carry mitochondrial proteins that reduce response to physical exercise

Keystone Symposia receives NIH grant for diversity initiatives

Medafor, Magle Life Sciences of Sweden sign long-term raw material supply agreement

Ligand Pharmaceuticals: GSK granted marketing authorization from EC for Revolade

Health bill update: Pelosi counting votes, Scott Brown lambastes Dems

Two controlled environmental variables to preclinical mice tests can reduce costly false positives: Study

New study finds green tea extract may prevent Alzheimer's disease and dementia

New hydrosurgery system may help manage excessive bleeding during surgery

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News